Lesson 8.7.1
8.7.1 Genome sequencing, personalised medicine and ethics Quiz: Pearson Edexcel Biology A (Salters-Nuffield), Unit 8
20 questions
In partnership with Revision Ninja
Lesson 8.7.1, Genome sequencing, personalised medicine and ethics: 20 multiple choice questions for the Pearson Edexcel Biology A (Salters-Nuffield) (9BI0), Unit 8: Grey Matter, written with Revision Ninja.
Host it live on the board and students join with a game code on their own devices, or revise alone with Free Play. The answers are revealed in the game.
The 20 questions
-
What does genome sequencing determine?
- The order of bases in an organism's DNA, using the letters A, T, C and G
- The speed of nerve impulses along the axons, which is measured by reading the genome of the neurone
- The number of cells in an organism, which is counted by sequencing each tissue in the body
- The concentration of glucose in blood, which is read from the sequence of the liver genes
-
What is personalised medicine?
- Producing medicines in a factory for all patients, which allows the same drug to be sold at low cost
- Treating disease only with surgery, which removes the need for drugs and genetic information entirely
- Tailoring diagnosis and treatment to an individual's genetic profile, to improve how well treatments work
- Using the same treatment for every patient regardless of their genetics, which keeps care consistent
-
Why can genome sequencing help in choosing a drug for a patient?
- It measures the patient's height, which determines the dose of every drug the patient needs
- It shows how a patient's genes may affect how they respond to a drug, including side effects
- It replaces all clinical trials, since the genome is enough to show whether a drug will work for everyone
- It shows the colour of the patient's skin only, which is the main factor in choosing a drug
-
Which technology has allowed genome sequencing to become much faster and cheaper than in the early Human Genome Project?
- Gel electrophoresis only, which separates DNA fragments by size but cannot read their base sequence
- Light microscopy, which allows the bases of individual DNA molecules to be seen and counted one by one
- Next-generation sequencing, which reads many DNA fragments in parallel and greatly lowers time and cost
- Radioactive decay counting, which measures the amount of DNA in a sample but not its sequence
-
Which ethical concern is raised by storing a person's genome data?
- Privacy and the risk that sensitive genetic information could be misused or disclosed without consent
- The risk that data will make the person taller, which is a concern for families planning children
- The cost of printing the report only, which is the main ethical issue in storing genome data
- The risk of reducing blood pressure, which may follow the release of genetic data to the patient
-
Which of the following is an ethical issue raised by personalised medicine?
- Medicine becomes less effective for all patients, since tailored drugs work less well than standard ones
- Unequal access, where only some patients can afford genetic testing and tailored treatment
- Every patient receives identical treatment, which removes any choice from the patient and their doctor
- Genes stop affecting health, which means that genetic information is no longer useful for any patient
-
A patient has a genetic variant that makes a drug less effective. What is the most appropriate response for personalised medicine?
- Stop all treatment, since a genetic variant means that no medicine can be useful for the patient
- Give the same dose regardless, since the variant does not change the way the drug is handled by the body
- Increase the dose until the effect appears, which is the standard approach for all genetic variants
- Choose an alternative drug or dose suited to the patient's genetic profile
-
Why is it useful to know a person's genetic risk of a disease before symptoms appear?
- It removes the need for any future healthcare, since the risk is then known and can be ignored
- It makes the disease certain to occur, so the person can prepare for the symptoms in advance
- It allows earlier monitoring or preventive action, which may improve outcomes
- It changes the DNA sequence in the person's cells, which removes the risk of the disease altogether
-
A student argues that genome sequencing will always predict disease perfectly. Which evaluation is most accurate?
- Correct, because sequencing gives a 100 per cent accurate diagnosis, which removes the need for any further test
- Overstated, because environment, lifestyle and gene interactions also affect risk, so predictions are probabilistic
- Incorrect, because genes never affect health, so sequencing cannot predict disease in any patient
- Correct, because the genome fully determines all health outcomes, so prediction is always exact
-
Which ethical concern is linked to genetic discrimination?
- People being treated unfairly, such as by employers or insurers, on the basis of their genetic information
- Patients losing their ability to see, which is the usual result of genetic testing for eye disease
- Hospitals using too much electricity, which is the main environmental concern in genetic testing centres
- People being given too much medicine, which is the main risk of tailoring treatment to genes
-
Which statement describes the purpose of informed consent in genome sequencing?
- To prevent any data from being shared with researchers, which keeps the genome data private for ever
- To guarantee that the sequence will cure disease, so that participants know the benefit in advance
- To make sure participants understand what their data will be used for, and agree to it
- To remove the need for ethical review, since consent makes the research automatically acceptable
-
A large population study finds a link between a gene variant and a higher risk of heart disease. Which statement is the most appropriate interpretation?
- The variant is associated with higher risk, but other factors also influence whether disease develops
- The variant causes heart disease in every carrier, so all carriers will develop the disease
- The variant has no relationship with heart disease, since the study found no effect in any individual
- The study shows that heart disease is not genetic, since the variant is only a marker of other causes
-
What is the role of the Human Genome Project in personalised medicine?
- It produced medicines that cure all diseases, which are now available for personalised use in every clinic
- It replaced the need for DNA, since the reference sequence can be used in place of individual genomes
- It identified the cell cycle, which is the main process used to tailor treatment to each patient
- It provided a reference sequence that makes it possible to compare individual genomes and find variation
-
Which factor is most likely to limit the uptake of personalised medicine in a health system?
- The colour of medical staff's uniforms, which can affect the trust that patients place in the clinic
- The size of the hospital car park, which restricts how many patients can attend genetic clinics each day
- Cost of sequencing, analysis and targeted drugs, and the need for specialist expertise
- The number of patients who have blood, which limits the amount of genetic material available for testing
-
Which of the following is an example of a genetic test that could inform treatment choice?
- Measuring body temperature, which can show whether a patient has a fever but cannot identify any gene
- Checking for broken bones, which is a standard imaging test that does not involve any genetic information
- Testing for a gene variant that affects how a patient breaks down a particular drug
- Counting white blood cells only, which shows the general state of the immune system but not the genes
-
Why must genetic data be handled with care in research?
- Because it cannot be stored electronically, which requires all records to be kept on paper in secure rooms
- Because sequencing destroys the genome, which means the sample cannot be used for any later analysis
- Because it can reveal information about relatives who did not consent, and is highly identifying
- Because DNA is always harmful to the person who provides the sample for the research study
-
A genetic test shows a 30 per cent chance of developing a condition. A patient reads this as a certain outcome. What is the best correction?
- The result means the condition will certainly occur, since any chance above zero is a diagnosis
- The result means there is a 30 per cent probability, so it is a risk rather than a certainty
- The result means the patient is immune to the condition, since a low probability gives protection from it
- The result means the condition is not inherited, since a probability of 30 per cent rules out genetic causes
-
Which statement is the best evaluation of whether personalised medicine improves healthcare for everyone?
- It only helps people who have no genes, since the genetic information of others makes treatment less useful
- It always helps everyone equally, with no costs or barriers, so it benefits all patients in the same way
- It has no benefit at all, since the same drugs work for every patient regardless of their genetic profile
- It has potential to improve outcomes, but equal access depends on cost, data protection and healthcare systems
-
A researcher uses a sequencing technique that reads 1 million fragments per run, with each run costing 500 pounds. How many runs are needed to read 5 million fragments?
- 10 runs, since each fragment needs two runs to be read in both directions for accurate sequencing
- 1 run, since the technique can read all fragments in a single run if the sample is prepared correctly
- 2 runs, since each run reads two million fragments when the samples are combined in one batch
- 5 runs, since 5 000 000 fragments divided by 1 000 000 fragments per run gives five runs
-
Which pair correctly matches an ethical issue with its concern?
- Privacy: data sharing without consent, which exposes personal genetic information
- Discrimination: improving drug dosage, which makes some groups receive worse treatment
- Confidentiality: reducing the number of DNA bases, which changes the information in the genome
- Access: making drugs cheaper for everyone, which is a concern when prices are set too low
Related quizzes
- Why animals need a circulation and the role of water Quiz · 1.1.1 · 20 questions
- Gas exchange surfaces and Fick's Law Quiz · 2.1.1 · 20 questions
- Common features of living cells Quiz · 3.1.1 · 20 questions
- Biodiversity, endemism and threats to variety of life Quiz · 4.1.1 · 20 questions
- Ecosystems, communities, populations and biotic and abiotic factors Quiz · 5.1.1 · 20 questions
- Time of death, decomposition and forensic entomology Quiz · 6.1.1 · 20 questions
- Structure and function of blood vessels Quiz · 1.1.2 · 20 questions
- Cell membrane structure and the fluid mosaic model Quiz · 2.1.2 · 20 questions
- Eukaryotic ultrastructure and electron micrographs Quiz · 3.1.2 · 20 questions
- Measuring biodiversity: heterozygosity and diversity index Quiz · 4.1.2 · 20 questions